BioSpace News Archive

Amgen presented positive topline data from the Phase II CodebreaK 100 trial of sotorasib in KRAS G12C-mutant advanced non-small cell lung cancer (NSCLC).

Allele Biotechnology and Pharmaceuticals filed lawsuits claiming the companies infringed on Allele’s patented mNeonGreen technology in the development of their COVID-19 treatments.

The probability of dying from COVID-19 depends more on age than gender, race or ethnicity, according to the first U.S. statewide random sample study of SARS-CoV-2 prevalence and fatalities.

A few days ago, CNBC reported that five patients, three in Moderna’s and two in Pfizer’s Phase III trials, had experienced more severe, although transient side effects.

Visible Genomics, a Chicago-area genetics testing company and founders of a non-invasive genetic eye test that determines a patient’s likelihood of contracting Age-Related Macular Degeneration (AMD), announced today that it has appointed Dr. Barry Eiden, Dr. Steven Ferrucci, Dr. Alan Glazier, and Dr. Treacy Adamo to its board of clinical advisors.

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 6, 2020.

Makena, the only FDA-approved treatment to reduce preterm birth failed to meet endpoints in a recent trial. The FDA gave notice of intent to withdraw approval.

The sticking point for the White House is a provision in the guidance that calls for vaccine manufacturers to follow people participating in late-stage clinical trials for a median of at least two months, starting after they receive a second vaccine shot.

In the October 2 verdict, Circuit Judge Pauline Newman said that promotional materials, press releases, product catalogs, FDA labels and witness testimony did support the “induced infringement” judgement against Teva.

Topline results from a 28-week Phase IIb trial show that lenabasum, a novel oral small molecule developed by Corbus Pharmaceuticals, did not reduce the rate of new pulmonary exacerbations compared with placebo in patients with cystic fibrosis.